Literature DB >> 2830471

Diapedesis and the permeability of venous microvessels to protein macromolecules: the impact of leukotriene B4 (LTB4).

R E Lewis1, H J Granger.   

Abstract

The cellular basis of the reported neutrophil-dependent increase in microvascular permeability evoked by leukotriene B4 (LTB4) was probed using protein intravascular fluorescent and electron dense tracers in conjunction with intravital, light and electron microscopy. LTB4 (1 microM) applied topically to the hamster cheek pouch promoted neutrophil (PMN) adherence to endothelial cells (ECs) and resulted in limited, diffuse leakage of fluorescein-labeled albumin from pericytic venules. ECs to which PMNs adhered displayed many vesicles and a prominent cytoskeletal reorganization of microfilaments. During emigration, microfilament-rich luminal extensions of ECs effectively resealed the endothelial barrier prior to or in conjunction with PMN penetration of the basal lamina. Intimate associations between PMNs and ECs, coupled with efficient bridging of the lumen by EC processes, argued against significant transendothelial escape of macromolecules concomitant with PMN egress. Studies employing horseradish peroxidase as an intravascular tracer suggested minimal enhancement of junctional permeability in small venules and refuted a role for vesicular transport. The primary apparent barrier defect was a selective alteration in the membrane integrity of a proportion of ECs.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2830471     DOI: 10.1016/0026-2862(88)90048-9

Source DB:  PubMed          Journal:  Microvasc Res        ISSN: 0026-2862            Impact factor:   3.514


  21 in total

1.  Proteinase 3 contributes to transendothelial migration of NB1-positive neutrophils.

Authors:  Christopher J Kuckleburg; Sarah B Tilkens; Sentot Santoso; Peter J Newman
Journal:  J Immunol       Date:  2012-01-20       Impact factor: 5.422

Review 2.  Leucocyte/endothelium interactions and microvessel permeability: coupled or uncoupled?

Authors:  Pingnian He
Journal:  Cardiovasc Res       Date:  2010-05-13       Impact factor: 10.787

Review 3.  Myosin light chain kinase in microvascular endothelial barrier function.

Authors:  Qiang Shen; Robert R Rigor; Christopher D Pivetti; Mack H Wu; Sarah Y Yuan
Journal:  Cardiovasc Res       Date:  2010-05-17       Impact factor: 10.787

4.  The dual roles of neutrophils and macrophages in inflammation: a critical balance between tissue damage and repair.

Authors:  Timothy A Butterfield; Thomas M Best; Mark A Merrick
Journal:  J Athl Train       Date:  2006 Oct-Dec       Impact factor: 2.860

5.  Endothelial gaps and adherent leukocytes in allergen-induced early- and late-phase plasma leakage in rat airways.

Authors:  P Baluk; P Bolton; A Hirata; G Thurston; D M McDonald
Journal:  Am J Pathol       Date:  1998-06       Impact factor: 4.307

6.  Effect of the leukotriene B4 receptor antagonist, SC-41930, on experimental allergic encephalomyelitis (EAE) in the guinea pig.

Authors:  D J Fretland; D L Widomski; R L Shone; S Levin; T S Gaginella
Journal:  Agents Actions       Date:  1991-09

Review 7.  Myosin light chain kinase signaling in endothelial barrier dysfunction.

Authors:  Robert R Rigor; Qiang Shen; Christopher D Pivetti; Mack H Wu; Sarah Y Yuan
Journal:  Med Res Rev       Date:  2012-08-09       Impact factor: 12.944

8.  Leukotriene B4-induced permeability increase in postcapillary venules and its inhibition by three different antiinflammatory drugs.

Authors:  M Erlansson; E Svensjö; D Bergqvist
Journal:  Inflammation       Date:  1989-12       Impact factor: 4.092

Review 9.  Leukocyte transendothelial migration: A local affair.

Authors:  Lilian Schimmel; Niels Heemskerk; Jaap D van Buul
Journal:  Small GTPases       Date:  2016-08-15

10.  Effects of leukotriene B4 in the human lung. Recruitment of neutrophils into the alveolar spaces without a change in protein permeability.

Authors:  T R Martin; B P Pistorese; E Y Chi; R B Goodman; M A Matthay
Journal:  J Clin Invest       Date:  1989-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.